Chargement en cours...

Value of innovation in hematologic malignancies: a systematic review of published cost-effectiveness analyses

We analyzed cost-effectiveness studies related to hematologic malignancies from the Tufts Medical Center Cost-Effectiveness Analysis Registry (www.cearegistry.org), focusing on studies of innovative therapies. Studies that met inclusion criteria were categorized by 4 cancer types (chronic myeloid le...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Blood
Auteurs principaux: Saret, Cayla J., Winn, Aaron N., Shah, Gunjan, Parsons, Susan K., Lin, Pei-Jung, Cohen, Joshua T., Neumann, Peter J.
Format: Artigo
Langue:Inglês
Publié: American Society of Hematology 2015
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4366623/
https://ncbi.nlm.nih.gov/pubmed/25655601
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2014-07-592832
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!